Theoretical Basis for Interest in Acetylprocainamide and Clinical Experiences with This New Antiarrhythmic Agent
- 1 January 1979
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 10 (2), 239-246
- https://doi.org/10.3109/03602537908997471
Abstract
In conclusion, it was the differential responses of slow and rapid acetylators to procainamide therapy that gave the initial clues that acetylprocainamide might be a safer drug than procainamide. So far, the experience with acetylprocainamide has been encouraging.Keywords
This publication has 17 references indexed in Scilit:
- Clinical consequences of polymorphic acetylation of basic drugsClinical Pharmacology & Therapeutics, 1977
- Cumulation of N‐acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal functionClinical Pharmacology & Therapeutics, 1977
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977
- Polymorphic acetylation of procainamide in manClinical Pharmacology & Therapeutics, 1975
- Antiarrhythmic potency of N‐acetylprocainamideClinical Pharmacology & Therapeutics, 1975
- ACETYLATION OF PROCAINE AMIDE IN MAN STUDIED WITH A NEW GAS CHROMATOGRAPHIC METHODBritish Journal of Clinical Pharmacology, 1974
- Hydralazine elimination in manClinical Pharmacology & Therapeutics, 1973
- ACETYLATION OF DRUGSPublished by Elsevier ,1973
- Relation of hydralazine plasma concentration to dosage and hypotensive actionClinical Pharmacology & Therapeutics, 1972
- Metabolism of procainamide in rhesus monkey and manClinical Pharmacology & Therapeutics, 1972